SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences informs about outcome of board meeting

04 Dec 2019 Evaluate

Gufic Biosciences has informed that the Board of Directors of the Company at its meeting held today ,Tuesday, December 03, 2019 considered and approved the Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2019, which are enclosed along with the Limited Review Report received from the Statutory Auditor of the Company on the said Un-Audited Financial Results. The meeting of the Board of Directors commenced at 08.00 pm and concluded at 10.00 pm.

The above information is a part of company’s filings submitted to BSE

Gufic Biosciences Share Price

301.30 -1.35 (-0.45%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×